6505--Emergency Breyanzi

Award Notice Posted

Solicitation number
6052521200172
Agency
Awarded
to Bristol-Myers Squibb Company
Set-aside
No set-aside

Opportunity facts

Contract number
36F79724D010136C26226N0738 Federal contract award
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a $364,139.25 contract to Bristol-Myers Squibb Company for the supply of Emergency Breyanzi on June 30, 2026.

The award was made under limited source justification citing FAR 8.405-6(a)(1)(A) for an urgent and compelling clinical need. Bristol-Myers Squibb is the sole authorized manufacturer and the only vendor with an FSS contract listing for Breyanzi on the VA National Acquisition Center Pharmaceutical Catalog. The period of performance is July 1, 2026 through July 31, 2026, representing a one-time purchase for VA Phoenix Health Care System. The acquisition supports treatment of a patient with relapsed or refractory B-cell lymphoma using this patient-specific, autologous CAR-T-cell immunotherapy. Manufacturing and infusion timelines for this REMS-certified therapy cannot accommodate extended procurement processes without clinical delay. Market research confirmed that identified small businesses lack capabilities to supply this specialized product. The contracting office is located in Long Beach, California. NAICS code 325412 applies.

Notice text

Awarded contract 36F79724D010136C26226N0738 to Bristol-Myers Squibb Company for 364139.25 on 2026-06-30.

Files

File Type Posted
36F79724D0101 36C26226N0738_1.docx DOCX document
Limited Source Justification_Redacted.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity